Heart Rate Variability Biofeedback Stress Relief Program for Depression^[*]

Summary

Background: Depressive disorders often have a chronic course and the efficacy of evidence-based treatments may be overestimated.

Objective: To examine the effectiveness of the Heart Rate Variability Stress Reduction Program (SRP) as a supplement to standard treatment in patients with depressive disorders.

Methods: The SRP was individually administered in eight weekly sessions. Seven participants completed the full protocol and were enrolled in a single-subject ABA multiple baseline experimental design. To perform interrupted time-series analyses, daily measures were completed in a diary (depression, resilience, happiness, heart coherence and a personalized outcome measure).

Results: Five out of seven patients improved in depressed mood and/or a personalized outcome measure. The effect of treatment was reversed in four patients during the withdrawal phase. One patient reliably improved on depression, whereas two patients recovered on autonomy and one on social optimism. No consistent relationship was found between the heart rate variability-related level of coherence and self-reported mood levels.

Conclusions: The SRP is beneficial in some domains and for some patients. A prolonged treatment or continued home practice may be required for enduring effects. The intervention had more clinical impact on resilience-related outcome measures than on symptoms. The small sample size does not permit generalization of the results. We recommend future investigation of the underlying mechanisms of the SRP.

Keywords

Heart rate variability - stress reduction - depression - resilience

¹ Supplementary material published on our website https://doi.org/10.3414/ME16-02-0033

• References

• 1 Vittengl JR, Clark LA, Thase ME, Jarrett RB. Nomothetic and idiographic symptom change trajectories in acute-phase cognitive therapy for recurrent depression. Journal of Consulting and Clinical Psychology 2013; 81 (04) 615-626 doi: 10.1037/ a0032879.
• 2 Penninx BW, Nolen WA, Lamers F, Zitman FG, Smit JH, Spinhoven P, Cuijpers P, de Jong PJ, van Marwijk HW, van der Meer K, Verhaak P, Laurant MG, de Graaf R, Hoogendijk WJ, van der Wee N, Ormel J, van Dyck R, Beekman AT. Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA). Journal of Affective Disorders 2011; 133 (1–2): 76-85 doi: 10.1016/j.jad.2011. 03.027.
• 3 Fava GA, Park SK, Sonino N. Treatment of recurrent depression. Expert Review of Neurotherapeutics 2006; 06 (11) 1735-1740 doi: 10.1586/ 14737175.6.11.1735.
• 4 Churchill R, Hunot V, Corney R, Knapp M, McGuire H, Tylee A, Wessely S. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technology Assessment (Winchester, England) 2001; 05 (35) 1-173.
• 5 de Maat SM, Dekker J, Schoevers RA, de Jonghe F. Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a metaanalysis. European Psychiatry 2007; 22 (01) 1-8 doi: 10.1016/j.eurpsy.2006.10.008.
• 6 Cuijpers P, van Straten A, van Oppen P, Andersson G. Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies. Journal of Clinical Psychiatry 2008; 69 (11) 1675-1685 quiz 1839–1841.
• 7 Cuijpers P, Dekker J, Hollon SD, Andersson G. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. Journal of Clinical Psychiatry 2009; 70 (09) 1219-1229 doi: 10.4088/JCP.09r05 021.
• 8 Cuijpers P, van Straten A, Warmerdam L, Andersson G. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depression and Anxiety 2009; 26 (03) 279-288 doi: 10.1002/ da.20519.
• 9 Hollon SD, DeRubeis RJ, Fawcett J, Amsterdam JD, Shelton RC, Zajecka J, Young PR, Gallop R. Effect of Cognitive Therapy with Antidepressant Medications vs Antidepressants Alone on the Rate of Recovery in Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2014; 71 (10) 1157-1164 doi: 10.1001/jamapsychiatry. 2014.1054.
• 10 Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry 2013; 12: 137-148.
• 11 Heartmath BeNeLux. Stress Reductie Programma Werkboek. Bunde: HeartMath BeNeLux; 2004
• 12 Hassett AL, Radvanski DC, Vaschillo EG, Vaschillo B, Sigal LH, Karavidas MK, Buyske S, Lehrer PM. A pilot study of the efficacy of heart rate variability (HRV) biofeedback in patients with fibromyalgia. Applied Psychophysiology and Biofeedback 2007; 32 (01) 1-10 doi: 10.1007/s10484– 006–9028–0.
• 13 Gevirtz RN. The promise of HRV biofeedback: Some preliminary results and speculations. Biofeedback 2003; 31 (03) 18-19.
• 14 Servant D, Logier R, Mouster Y, Goudemand M. Heart rate variability. Applications in psychiatry. [La variabilite de la fréquence cardiaque. Intérêts en psychiatrie]. L’Encephale 2009; 35 (05) 423-428 doi: 10.1016/j.encep.2008.06.016. French.
• 15 Agelink MW, Boz C, Ullrich H, Andrich J. Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychiatry Research 2002; 113 (1–2): 139-149.
• 16 Yeragani VK, Rao KA, Smitha MR, Pohl RB, Balon R, Srinivasan K. Diminished chaos of heart rate time series in patients with major depression. Biological Psychiatry 2002; 51 (09) 733-744.
• 17 Karavidas MK, Lehrer PM, Vaschillo E, Vaschillo B, Marin H, Buyske S, Malinovsky I, Radvanski D, Hassett A. Preliminary results of an open label study of heart rate variability biofeedback for the treatment of major depression. Applied Psychophysiology and Biofeedback 2007; 32 (01) 19-30 doi: 10.1007/s10484–006–9029-z.
• 18 Siepmann M, Aykac V, Unterdorfer J, Petrowski K, Mueck-Weymann M. A pilot study on the effects of heart rate variability biofeedback in patients with depression and in healthy subjects. Applied Psychophysiology and Biofeedback 2008; 33 (04) 195-201 doi: 10.1007/s10484–008–9064-z.
• 19 Rottenberg J. Cardiac vagal control in depression: a critical analysis. Biological Psychology 2007; 74 (02) 200-211 doi: 10.1016/j.biopsycho.2005. 08.010.
• 20 McCraty R, Tomasino D. Emotional stress, positive emotions and psychophysiological coherence. In: Arntz BB, Ekman R. editors. Stress in health and disease. Weinheim: Wiley-VCH; 2006: 360-383.
• 21 Ratanasiripong P, Ratanasiripong N, Kathalae D. Biofeedback Intervention for Stress and Anxiety among Nursing Students: A Randomized Controlled Trial. ISRN Nursing. 2012: 827972 doi: 10.5402/2012/827972.
• 22 Henriques G, Keffer S, Abrahamson C, Horst SJ. Exploring the effectiveness of a computer-based heart rate variability biofeedback program in reducing anxiety in college students. Applied Psychophysiology and Biofeedback 2011; 36 (02) 101-112 doi: 10.1007/s10484–011–9151–4.
• 23 Lemaire JB, Wallace JE, Lewin AM, de Grood J, Schaefer JP. The effect of a biofeedback-based stress management tool on physician stress: a randomized controlled clinical trial. Open Medicine 2011; 05 (04) e154-63.
• 24 Wichers M, Myin-Germeys I, Jacobs N, Peeters F, Kenis G, Derom C, Vlietinck R, Delespaul P, Van Os J. Genetic risk of depression and stress-induced negative affect in daily life. British Journal of Psychiatry 2007; 191: 218-223 doi: 10.1192/bjp.bp. 106.032201.
• 25 Barlow DH, Nock MK. Why can’t we be more ideographic in our research. Perspectives on Psychological Science 2009; 04 (01) 19-21 doi: 10.1111/j.1745–6924.2009.01088.x.
• 26 Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ. The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?. Personalized Medicine 2011; 08 (02) 161-173 doi: 10.2217/ pme.11.7.
• 27 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994
• 28 Beck AT, Steer RA, Brown GK. Manual for Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996
• 29 Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Weissman MM. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry 1991; 48 (09) 851-855.
• 30 Ottenbacher KJ, Hinderer SR. Evidence-based practice: methods to evaluate individual patient improvement. American Journal of Physical Medicine & Rehabilitation/Association of Academic Physiatrists 2001; 80 (10) 786-796.
• 31 Appelo MT. De Positieve Uitkomsten Lijst (PUL). Handleiding. Nijmegen: Cure & Care Tests; 2005
• 32 Veenhoven R. Correlates of happiness, 7838 findings from 603 studies in 69 nations 1911–1994. RISBO, studies in social and cultural transformation. 3rd ed. Rotterdam: Erasmus University; 1994
• 33 Hartmann DP, Gottman JM, Jones RR, Gardner W, Kazdin AE, Vaught RS. Interrupted time-series analysis and its application to behavioral data. Journal of Applied Behavior Analysis 1980; 13 (04) 543-559.
• 34 Van der Does AJW. BDI-II-NL. Handleiding. De Nederlandse versie van de Beck Depression Inventory. 2nd ed. Lisse: Harcourt Test Publishers; 2002
• 35 Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE. Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. International Journal of Technology Assessment in Health Care 2003; 19 (04) 613-623.
• 36 Huitema BE, McKean JW. A simple and powerful test for autocorrelated errors in OLS intervention models. Psychological Reports 2000; 87 (01) 3-20 doi: 10.2466/pr0.2000.87.1.3.
• 37 Kazdin AE. Single-case research designs. 2nd ed. New York, NY: Oxford University Press; 2011
• 38 Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 1991; 59 (01) 12-19.
• 39 Bauer S, Lambert MJ, Nielsen SL. Clinical significance methods: a comparison of statistical techniques. Journal of Personality Assessment 2004; 82 (01) 60-70 doi: 10.1207/s15327752jpa 8201_11.
• 40 Germer CK. The Mindful Path to Self-Compassion. New York: Guilford Press; 2009
• 41 Neff KD. Self-Compassion. Stop Beating Yourself Up and Leave Insecurity Behind. New York, NY: HarperCollins; 2011
• 42 Gilbert P. Compassion Focused Therapy. Distinctive Features. London: Routledge; 2010
• 43 Rockliff H, Gilbert P, McEwan K, Lightman S, Glover D. A pilot exploration of heart rate variability and salivary cortisol responses to compassionfocussed imagery. Clinical Neuropsychiatry 2008; 05 (03) 132-139.
• 44 Lehrer PM, Vaschillo E, Vaschillo B. Resonant frequency biofeedback training to increase cardiac variability: rationale and manual for training. Applied Psychophysiology and Biofeedback 2000; 25 (03) 177-191.
• 45 McCraty R, Atkinson M, Tomasino D. Impact of a workplace stress reduction program on blood pressure and emotional health in hypertensive employees. Journal of Alternative and Complementary Medicine 2003; 09 (03) 355-369 doi: 10.1089/ 107555303765551589.
• 46 Houtveen JH, Hornsveld HK, Van Trier J, Van Doornen LJP. Vraagtekens bij het werkingsmechanisme van slow-breathing en hartcoherentietraining. Tijdschrift voor Psychiatrie 2012; 10 (54) 879-888.
• 47 Hoffman JW, Benson H, Arns PA, Stainbrook GL, Landsberg GL, Young JB, Gill A. Reduced sympathetic nervous-system responsivity associated with the relaxation response. Science 1982; 215 (4529): 190-192.
• 48 Fredrickson B. Positivity. New York: Crown; 2009
• 49 Rissanen A, Naukkarinen H, Virkkunen M, Rawlings RR, Linnoila M. Fluoxetine normalizes increased cardiac vagal tone in bulimia nervosa. Journal of Clinical Psychopharmacology 1998; 18 (01) 26-32.
• 50 Volkers AC, Tulen JH, van den Broek WW, Bruyn JA, Passchier J, Pepplinkhuizen L. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder. Pharmacopsychiatry 2004; 37 (01) 18-25 doi: 10.1055/s-2004–815470.
• 51 Bar KJ, Greiner W, Jochum T, Friedrich M, Wagner G, Sauer H. The influence of major depression and its treatment on heart rate variability and papillary light reflex parameters. Journal of Affective Disorders 2004; 82 (02) 245-252 doi: S016503270 400031X.
• 52 Rechlin T. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability. Journal of Clinical Psychopharmacology 1994; 14 (06) 392-395.
• 53 Rechlin T, Weis M, Claus D. Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions. Pharmacopsychiatry 1994; 27 (03) 124-128 doi: 10.1055/s-2007–1014291.
• 54 Roose SP, Glassman AH, Attia E, Woodring S, Giardina EG, Bigger JT. Cardiovascular effects of fluoxetine in depressed patients with heart disease. American Journal of Psychiatry 1998; 155 (05) 660-665.